Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants

European Heart Journal

Volumn 36, Issue 21, 2015, Pages 1297-1305

  Koertke, Heinrich ^a   Zittermann, Armin ^a   Wagner, Otto ^a   Secer, Songuel ^a   Huth, Christof ^b   Sciangula, Alfonso ^c   Saggau, Werner ^d   Sack, Falk Udo ^d   Ennker, Jürgen ^e   Cremer, Jochen ^f   Musumeci, Francesco ^g   Gummert, Jan F ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c SantAnna Hospital   (Italy)

^d Academic City Hospital   (Germany)

^e Department of Cardiac Surgery   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Bleeding event; International normalized ratio; Mechanical heart valve replacement; Oral anticoagulation; Thrombotic event; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; ANTICOAGULANT AGENT; VITAMIN K GROUP;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOUBLE VALVE REPLACEMENT; FEMALE; FOLLOW UP; HEART VALVE REPLACEMENT; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; INTERNATIONAL NORMALIZED RATIO; LEG ISCHEMIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; MIDDLE AGED; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY; OPEN STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SELF CONTROL; TELEMEDICINE; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANTAGONISTS AND INHIBITORS; AORTA VALVE; BLEEDING; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG ADMINISTRATION; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; MITRAL VALVE; PROCEDURES; THROMBOEMBOLISM; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTICOAGULANTS; AORTIC VALVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; MITRAL VALVE; SELF CARE; TELEMEDICINE; THROMBOEMBOLISM; TREATMENT OUTCOME; VITAMIN K; YOUNG ADULT;

EID: 84942425643     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu330     Document Type: Article

References (18)

1. Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van deWerf F; RE-ALIGNInvestigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369: 1206-1214.
2. Horstkotte D, Piper C. Improvement of oral anticoagulation therapy by INR selfmanagement. J Heart Valve Dis 2004;13:335-338.
3. Odén A, Fahlén M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 2002;325:1073-1075.
4. Penning-van Beest FJ, Geleijnse JM, van Meegen E, Vermeer C, Rosendaal FR, Stricker BH. Lifestyle and diet as risk factors for overanticoagulation. J Clin Epidemiol 2002;55:411-417.
5. Koertke H, Zittermann A, Mommertz S, El-Arousy M, Litmathe J, Koerfer R. The Bad Oeynhausen concept of INR self-management. J Thromb Thrombolysis 2005;19: 25-31.
6. Heneghan C, Ward A, Perera R, Bankheada C, Fullera A, Stevensa R, Bradford K, Tyndel S, Alonso-Coello P, Ansell J, Beyth R, Bernardo A, Christensen TD, Cromheecke ME, Edson RG, Fitzmaurice D, Gadisseur AP, Garcia-Alamino JM, Gardiner C, Hasenkam JM, Jacobson A, Kaatz S, Kamali F, Khan TI, Knight E, Körtke H, Levig M, Matchar D, Menéndez-Jándula B, Rakovac I, Schaefer C, Siebenhofer-Kroitzsch A, Souto JC, Sunderji R, Gin K, Shalansky K, Völler H, Wagner O, Zittermann A. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012;379:322-334.
7. Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11-17.
8. The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
9. Koertke H, Zittermann A, Tenderich G,Wagner O, El-Arousy M, Krian A, Ennker J, Taborski U, KlövekornWP, Moosdorf R, SaggauW, Koerfer R. Low-dose oral anticoagulants in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 2007;28:2479-2484.
10. Nozawa T, Inoue H, Iwasa A, Okumura K, Jong-dae L, Shimizu A, Hayano M, Yano K. Effects of anticoagulation intensity on hemostatic markers in patients with nonvalvular atrial fibrillation. Circ J 2004;68:29-34.
11. Koertke H, Zittermann A,Wagner O, Ennker J, SaggauW, Sack F, Cremer J, Huth C, Braccio M, Musumeci F, Koerfer R. Efficacy and safety of very low dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Ann Thorac Surg 2010;90:1487-1494.
12. Plesch W, van den Besselaar AM. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009;31:20-25.
13. Mueller S, Pfannkuche M, Breithardt G, Bauersachs R, Maywald U, Kohlmann T, Wilke T. The quality of oral anticoagulation in general practice in patients with atrial fibrillation. Eur J Intern Med 2014;25:247-254.
14. Torella M, Torella D, Chiodini P, Franciulli M, Romano G, De Santo L, De Feo M, Amarelli C, Sasso FC, Salvatore T, Ellison GM, Indolfi C, Cotrufo M, Nappi G. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the 'LOWERING-IT' Trial. Am Heart J 2010;160:171-178.
15. Herijgers P, Verhamme P. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Eur Heart J 2007;28: 2424-2426.
16. Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Koefer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg 2005;80:1699-1705.
17. VolkertD, Kreuel K, Stehle P. Nutrition beyond 65-amount of usual drinking fluid and motivation to drink are interrelated in community-living, independent elderly people. Z Gerontol Geriatr 2004;37:436-443 (in German).
18. http://www.onxlti.com/heart-valves/patients-and-families/about-anti coagulation (assessed 5 November 2013).